Acidity-targeting transition-aided universal chimeric antigen receptor T-cell (ATT-CAR-T) therapy for the treatment of solid tumors.
Shi T, Sun M, Tuerhong S, Li M, Wang J, Wang Y, Zheng Q, Zou L, Lu C, Sun Z, Zou Z, Shao J, Du J, Li R, Liu B, Meng F.
Shi T, et al. Among authors: du j.
Biomaterials. 2024 May 7;309:122607. doi: 10.1016/j.biomaterials.2024.122607. Online ahead of print.
Biomaterials. 2024.
PMID: 38759487